Phlegmonous abscess associated with etanercept therapy.
D'Amore
M
M
Minenna
G
G
Favoino
E
E
D'Amore
S
S
D000038:Abscess / Q000139:chemically induced* / Q000382:microbiology*; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001424:Bacterial Infections / Q000150:complications*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007568:Jaw; D009181:Mycoses / Q000150:complications*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept